Tech doesn't have to add more screen time to the lives of kids; these Christmas gift ideas are great for children and the ...

Eli Lilly and Company today announced that the National Medical Products Administration (NMPA) in China has approved Kisunlatm (donanemab-azbt, 350 mg/20 mL every four weeks injection for IV infusion) ...